Biotage logo

Biotage

Ação
Ação
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT

Price

Gráfico do Preço

GRÁFICO POR

Dividendos históricos e previsões

 


0,114

GRÁFICO POR

Perguntas mais frequentes

Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0,322. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Biotage's stock, with a consensus target price of US$ 14,61. Analyst ratings provide insights into the stock's expected performance.
Durante os últimos doze meses, a Biotage registou uma receita de US$ 197,56 mi.
O lucro antes de juros, impostos, depreciação e amortização (EBITDA) da Biotage durante os últimos doze meses é de US$ 47,05 mi. O EBITDA mede o desempenho financeiro global da empresa.
A empresa Biotage tem um fluxo de caixa livre de US$ 26,60 mi. O fluxo de caixa livre indica o dinheiro gerado após a contabilização das saídas de caixa para apoiar as operações e os activos de capital.
A Biotage emprega aproximadamente 673 pessoas. Desenvolve a sua atividade no sector Cuidados de saúde, especificamente na indústria Especialidades Médicas.

Finanças

EPS (TTM) 
0,322
Receita (TTM) 
US$ 197,56 mi
EBITDA (TTM) 
US$ 47,05 mi
Cashflow livre (TTM) 
US$ 26,60 mi

Avaliações dos analistas

O preço-alvo é de US$ 14,61 e o stock é coberto por 1 analistas.

Comprar

0

Manter

1

Vender

0

Informações

Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.

Empregados
673
Indústrias
Especialidades Médicas
Sector
Cuidados de saúde

Identificador

ISIN
SE0000454746
Rastreador primário
BIOT

Knockouts

Dados tempo real da LSX · Dados financeiros e EOD da FactSet
Participar na conversa